跳至主要内容
临床试验/CTRI/2023/08/056323
CTRI/2023/08/056323尚未招募Phase 3 4

A comparative clinical study to evaluate the efficacy of Amrutadi Guggul and Tryushnadi Guggul in Sthaulya

Dr Vaibhav Raju Badgujar1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2023年11月9日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
66
试验地点
1
主要终点
To compare the efficacy of Amrutadi Guggul and Tryushanadi Guggul in Sthaulya.

研究概览

简要总结

In present era ,the problems with digestion and obesity are increasing day to day .Due tosedentary life style , junk food eating ,stress ,lack of exercise ,there are major chances of weightgain and obesity . Obesity is defined as abnormal or excessive fat accumulation that present risk to health ,causingmajor risk for a number of hypertension, restlessness,fatigue,excess perspiration and lackcheerfulness. In modern medicine, statins , lipid lowering drugs is only available treatment. It maycause some adverse effects on cardiac system, renals, bones after long term use.[5]Previous study was carried out is comparative clinical efficacy of Amrutadi Guggul and NavakadiGuggul in Sthaulya .Comparative study of Amrutadi Guggul with Tryushanadi Guggul .In the mentioned studyAmrutadi Guggul turned out to be better drugNow,this study is being conducted to compare efficacy of both better proven drugs in presentstudies with each other to know which is more effect .

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients from age group of 21 to 60 years irrespective of gender, religion, socioeconomic status, marital status.
  • Patients of Sthaulya i.e.as per signs and symptoms BMI >25 to
  • including overweight Obese Class I,II,III (shown in table 1) an as per signs and symptoms mentioned in Ayurvedic texts.
  • BMI >25 4) Waist To Hip Ratio more than 1.0 5) Drug induced Obesity e.g. Corticosteroids; anxiolytics; Sulfonylureas; Insulin.
  • Obesity due to excessive calories.
  • Obesity due to lack of Exercise.
  • Skin Fold Thickness(over mid triceps) between 20-24.5mm(in Male) and 28-32mm(in Female).

排除标准

  • Pregnant women, lactating mother.
  • Acute life threatening conditions like C.V.A., Acute M.I.; Endocrine disorders.
  • Known Cases of Hypothyroidism.
  • Hormonal imbalanced obesity like PCOD.

结局指标

主要结局

To compare the efficacy of Amrutadi Guggul and Tryushanadi Guggul in Sthaulya.

时间窗: 0th day 30th day 60th day

次要结局

  • To observe the adverse effects of Amrutadi Guggul and Trushanadi Guggul in Sthaulya(0th day 30th day 60th day)

研究者

发起方
Dr Vaibhav Raju Badgujar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验